KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lam Research (LRCX) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Lam Research (LRCX) over the last 16 years, with Q4 2025 value amounting to $1.0 billion.

  • Lam Research's Accounts Payables rose 2488.93% to $1.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.0 billion, marking a year-over-year increase of 2488.93%. This contributed to the annual value of $854.2 million for FY2025, which is 3912.95% up from last year.
  • As of Q4 2025, Lam Research's Accounts Payables stood at $1.0 billion, which was up 2488.93% from $863.2 million recorded in Q3 2025.
  • Over the past 5 years, Lam Research's Accounts Payables peaked at $1.1 billion during Q3 2022, and registered a low of $470.7 million during Q2 2023.
  • In the last 5 years, Lam Research's Accounts Payables had a median value of $833.7 million in 2021 and averaged $791.8 million.
  • In the last 5 years, Lam Research's Accounts Payables plummeted by 5392.4% in 2023 and then surged by 6455.3% in 2024.
  • Quarter analysis of 5 years shows Lam Research's Accounts Payables stood at $952.7 million in 2021, then dropped by 3.49% to $919.4 million in 2022, then crashed by 45.65% to $499.7 million in 2023, then skyrocketed by 64.55% to $822.3 million in 2024, then increased by 24.89% to $1.0 billion in 2025.
  • Its Accounts Payables stands at $1.0 billion for Q4 2025, versus $863.2 million for Q3 2025 and $854.2 million for Q2 2025.